Clicky

Castle Biosciences, Inc.(CSTL)

Description: Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, which is a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.


Keywords: Medicine Cancer Clinical Medicine Melanoma Medical Test Gene Expression Metastasis Dsw Uveal Melanoma

Home Page: castlebiosciences.com

CSTL Technical Analysis

505 South Friendswood Drive
Friendswood, TX 77546
United States
Phone: 866 788 9007


Officers

Name Title
Mr. Derek J. Maetzold Founder, CEO, Pres & Director
Mr. Frank Stokes CFO & Treasurer
Ms. Kristen M. Oelschlager R.N., RN Chief Operating Officer
Mr. Toby W. Juvenal Chief Commercial Officer
Camilla Zuckero Exec. Director of Investor Relations & Corp. Communications
Ms. Alice Bahner Izzo Sr. VP of Marketing
Ms. Keli Greenberg VP of HR & Exec. Director of HR
Dr. Robert W. Cook Ph.D. Sr. VP of R&D
Mr. Bernhard E. Spiess Company Sec.
Mr. John W. Abbott VP & Controller

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.5916
Price-to-Sales TTM: 5.258
IPO Date: 2019-07-25
Fiscal Year End: December
Full Time Employees: 517
Back to stocks